XyloCor Therapeutics CEO Al Gianchetti departs to lead another biotech company

January 7, 20261 Min Read

Al Gianchetti spent the last 10 years as CEO of King of Prussia-based XyloCor following more than 24 as a vice president at GSK.

Read More from Bizjournals.com Feed (2025-02-17 17:26:56)

Over the past decade, compensation for artificial intelligen...

When it comes to purchasing B2B software, buyers and vendors...

Company Overview Company: Captain IT Address: 1465 Spruce...

Post sponsored by Mobile IV Nurses In This Article How to...

Post sponsored by Trustaff A persistent and critical nursing...

Opinion

Vladimir Putin has been lying to Donald Trump and ...

We arrested an illegitimate leader and removed him...

Why do so many progressives absolutely love the id...

Democrats are taking advantage of voter dissatisfa...

For many households today, the binding constraint ...

Discover more from ZoomHoot - The Important Information You Need